Halberd Corporation Adds Blood-Borne Disease Treatment Capability with Addition of Noted Nephrologist
Jackson Center, Pennsylvania--(Newsfile Corp. - August 11, 2021) - Halberd Corporation (OTC Pink: HALB) today confirmed the addition of Dr. Ned Kronfol as a member of its Scientific Advisory Board. Dr. Kronfol is certified by the American Board of Internal Medicine and retired in 2019 as Adjunct Clinical Professor from the William Carey University College of Osteopathic Medicine. Among many other notable accomplishments, Dr. Kronfol served as Medical Director- Renal Care Group/Fresenius...
2021-08-11 8:00 AM EDT
Halberd Corporation's VITA-SHIELD-MAX(TM) Immunity Support Product Shipped
Jackson Center, Pennsylvania--(Newsfile Corp. - August 9, 2021) - Halberd Corporation (OTC Pink: HALB) reports Vita-Shield-MaxTM, has been shipped! With COVID-19 cases back on the rise fueled by the Delta Variant, this "Immunity Support Nutraceutical Product" is arriving at the right time.William A. Hartman, Halberd's Chairman, President & CEO, stated, "We will shortly begin selling Vita-Shield-MaxTM and will be releasing details on purchasing our product in the near future, once we have the...
2021-08-09 8:00 AM EDT
Halberd Corporation Successfully Establishes Disease Eradication Proof-of-Concept - "Never Before Accomplished"
Jackson Center, Pennsylvania--(Newsfile Corp. - July 28, 2021) - Halberd Corporation (OTC Pink: HALB) establishes "proof of concept" taking a major step towards the elimination of multiple infectious diseases, such as, malaria, tuberculosis, sepsis, meningitis, and pandemics, among others, by successfully eliminating E. Coli bacteria through the use of its patent-pending laser emissive energy exposure technique. Recently, at Youngstown State University (YSU) and Arizona State University...
2021-07-28 8:00 AM EDT
Halberd Corp. Advances the Elimination of Antigens Present in Alzheimer's Disease & PTSD/Chronic Traumatic Encephalopathy
Jackson Center, Pennsylvania--(Newsfile Corp. - July 22, 2021) - Halberd Corporation (OTC Pink: HALB) confirms the shipment of samples of metallic nanoparticles conjugated to Alzheimer's Disease (AD) antibodies, Tau and Phosphorylated Tau. Having successfully conjugated the metallic nanoparticles (via its breakthrough patent-pending process), GreenBioAZ shipped the materials to Youngstown State University (YSU). At YSU, Dr. William G. Sturrus, Chair of the Physics, Astronomy, Geology, and...
2021-07-22 8:00 AM EDT
Halberd Corporation CEO Letter
Jackson Center, Pennsylvania--(Newsfile Corp. - July 6, 2021) - Greetings From The CEO And Staff At HALBERD CORPORATION! (OTC Pink: HALB)As we began the second quarter, the company, along with the rest of the country, was focused on developing antibodies against Covid-19 that could be used as therapeutic and/or diagnostic tools. Because of the apparent effectiveness of the vaccines and other measures, Covid cases have decreased dramatically, necessitating a reprioritization of Halberd's...
2021-07-06 8:00 AM EDT
Halberd Corp. Discovers a Proprietary Disease-Causing Antigen Removal Process
Jackson Center, Pennsylvania--(Newsfile Corp. - June 30, 2021) - Halberd Corporation (OTC Pink: HALB) announces a possible breakthrough method for the removal of the disease-causing antigen(s) that does not require the use of metallic nanoparticles conjugated to antibodies. This simplified method for the removal of disease-causing antigen(s) utilizes more conventional medical equipment found in hospitals and clinics and utilizes our patented extracorporeal treatment process. The method...
2021-06-30 8:00 AM EDT
Halberd Corporation's Proprietary Technology for Alzheimer's Disease Enters Stage 4 of 7 Stage Process
Jackson Center, Pennsylvania--(Newsfile Corp. - June 21, 2021) - Halberd Corporation's (OTC Pink: HALB) proprietary technology enters stage 4 to address Alzheimer's Disease (and other potential diseases); eradicating the antibody-disease combination through radiofrequency waves or laser or other means. Currently, there is no known effective treatment for Alzheimer's Disease which afflicts over 40 million people worldwide, equivalent to the combined population of the states of Florida and New...
2021-06-21 8:00 AM EDT
Halberd Corporation Successfully Conjugates Metallic Particles and Antibodies Against Alzheimer's Disease-Associated Antigens
Jackson Center, Pennsylvania--(Newsfile Corp. - June 16, 2021) - Halberd Corporation (OTC Pink: HALB) has successfully conjugated Tau, Phosphorylated Tau and Beta Amyloid antibodies with gold-coated iron oxide nanoparticles in a patent-pending process. These three antigens, which are found in Cerebral Spinal Fluid (CSF), are associated with the formation of neurofibrillary tangles concomitant with Alzheimer's Disease. Conjugation of these antibodies with gold-coated iron oxide particles...
2021-06-16 8:00 AM EDT
Halberd Corporation Undertakes Process Toward the Elimination of Alzheimer's Disease
Jackson Center, Pennsylvania--(Newsfile Corp. - June 9, 2021) - Halberd Corporation (OTC Pink: HALB) commences experimentations to eradicate three of the principal components of Alzheimer's Disease. By eliminating these three critical antigens, which form the basis for neurofibrillary tangles in the brain, Halberd believes that its patented extracorporeal treatment process can slow or stop the progress of the disease.Dr. Mitchell S. Felder, Halberd Corporation's Chief Technical Officer and...
2021-06-09 8:00 AM EDT
Halberd Corp. Files Provisional Patent Application Complementing Patented Extracorporeal Radio Frequency/Laser Projects
Jackson Center, Pennsylvania--(Newsfile Corp. - June 1, 2021) - Halberd Corp. (OTC Pink: HALB) announced the filing of a U. S. joint provisional patent application titled, "Antibody Conjugated Nanoparticle Assay And Treatment For SARS-CoV-2." The innovation is a result of Halberd's Sponsored Research conducted at Arizona State University (ASU). The provisional patent application covers technology developed to facilitate conjugation of metallic nanoparticles with antibodies against various...
2021-06-01 8:00 AM EDT
Halberd Announces Agreement to Retire 192,000,000 Outstanding Common Shares and Acquisition/Joint Venture to Be Announced, in Detail, This Week
Lake Charles, Louisiana--(Newsfile Corp. - April 6, 2020) - Halberd Corporation (OTC Pink: HALB) announces that it has reached an agreement with shareholders holding 192,000,000 shares of the 482,838,125 reported as currently outstanding. Those shares will be returned to treasury and retired. We are also reducing the authorized shares of common stock to 1,000,000,000.Mr. LeDoux, the new CEO, explained that "perhaps even before becoming compliant with our reporting obligations with OTCMarkets,...
2020-04-06 2:19 PM EDT
Halberd Moves Forward - Announces New CEO, Commences Process to Become Current, Holding Company Reorganization
Lake Charles, Louisiana--(Newsfile Corp. - April 3, 2020) - Halberd Corporation (OTC Pink: HALB) announces that James Christopher LeDoux is the new CEO.Mr. LeDoux explains that "Halberd is now current in its filings with the Colorado Secretary of State. The Colorado state filings include, as a prophylactic measure to assure a smooth transition to its new endeavor, a holding company reorganization. As such, Halberd Corporation as it is currently constituted, is the successor issuer, has a...
2020-04-03 12:33 PM EDT